WNT11 and breast cancer: In colorectal cancer (CRC), pancreatic ductal adenocarcinoma (PDAC), and breast cancer—the major sources of LM—WNT11 has been associated with epithelial–mesenchymal transition (EMT), matrix remodeling, and stromal reprogramming (14).